Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:37 AM
Ignite Modification Date:
2025-12-25 @ 12:37 AM
NCT ID:
NCT05828667
Eligibility Criteria:
Inclusion Criteria:
* Patients (\>18 years old) diagnosed with severely reduced ejection fraction defined as EF≤25% or EF≤ 35% with concurrent NYHA class III/IV heart failure symptoms and/or at least one previous heart failure hospitalization in the previous 6 months) who are referred for VT ablation.
* Patients with moderate to severe RV dysfunction diagnosed on most recent imaging (echo/c-MRI).
* Patients with must have undergone the imaging (c-MRI and/or CT) required for the investigational VT approach to qualify for participation.
Exclusion Criteria:
* Patients in whom Impella/ECMO or anesthesia is indicated prior to or at presentation to the EP lab.
* Patients for whom an informed consent cannot be obtained.
* Patients who are found to be pregnant using detection of human chorionic gonadotropin (hcg) as done as part of standard of care, will be excluded.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT05828667
Study Brief:
Protocol Section:
NCT05828667